Ad is loading...
CUSRX
Price
$15.16
Change
-$0.21 (-1.37%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

CUSRX vs VISVX

Header iconCUSRX vs VISVX Comparison
Open Charts CUSRX vs VISVXBanner chart's image
Cullen Small Cap Value Retail
Price$15.16
Change-$0.21 (-1.37%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
CUSRX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CUSRX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUSRX is a Sell and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. CUSRX (11.9M). VISVX pays higher dividends than CUSRX: VISVX (1.90) vs CUSRX (1.05). CUSRX was incepted earlier than VISVX: CUSRX (15 years) vs VISVX (27 years). CUSRX is a more actively managed with annual turnover of: 70.00 vs. VISVX (16.00). CUSRX has a lower initial minimum investment than VISVX: CUSRX (1000) vs VISVX (3000). CUSRX (29.74) and VISVX (28.71) have marching annual gain over last year. VISVX return over 5 years is better than : 57.32 vs. CUSRX (32.14).
CUSRXVISVXCUSRX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years27 years-
Gain YTD12.47715.43381%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets11.9M57.6B0%
Annual Yield % from dividends1.051.9055%
Returns for 1 year29.7428.71104%
Returns for 3 years-5.5313.23-42%
Returns for 5 years32.1457.3256%
Returns for 10 years3.60108.213%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics